Association between creatine kinase level and mortality in high-risk patients with COVID-19
A. Kitbalian (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), P. Potapov (Moscow, Russian Federation), A. Moiseev (Moscow, Russian Federation), A. Schepalina (Moscow, Russian Federation), A. Yakovleva (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation)
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Session: COVID - 19 biomarkers
Session type: E-poster
Number: 650
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kitbalian (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), P. Potapov (Moscow, Russian Federation), A. Moiseev (Moscow, Russian Federation), A. Schepalina (Moscow, Russian Federation), A. Yakovleva (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation). Association between creatine kinase level and mortality in high-risk patients with COVID-19. 650
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Association of plasma level of Mixed lineage kinase domain-like protein with severity and outcome of sepsis Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science Year: 2021
Association between C-reactive protein levels and outcome in acute lung injury in children Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011
Creatine kinase enzyme is carbonylated in the quadriceps of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 242s Year: 2005
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors Source: ERJ Open Res, 3 (3) 00092-2016; 10.1183/23120541.00092-2016 Year: 2017
C-reactive protein levels and the risk of COPD in a general population: the Rotterdam study Source: Annual Congress 2007 - Mechanisms and new treatments of COPD Year: 2007
C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD Year: 2008
High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study Source: Eur Respir J, 55 (2) 1901314; 10.1183/13993003.01314-2019 Year: 2020
Usefulness of troponin-I, lactate, C-reactive protein as a prognostic markers in critically ill non-cardiac patients Source: Eur Respir J 2006; 28: Suppl. 50, 181s Year: 2006
PP302 – The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension Source: ERS Lung Science Conference 2021 Year: 2021
LSC - 2021 - The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021
C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Clinical profile of newly diagnosed patients of non small cell carcinima with epidermal growth factor receptor positivity on oral tyrosine kinase inhibitor therapy Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013
The study on the association of serum C-reactive protein level with the risk of lung cancer Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009
Usefulness of troponin-1, lactate and c-reactive protein as a prognostic markers in critically ill, non cardiac patients Source: Eur Respir J 2005; 26: Suppl. 49, 436s Year: 2005
Association of serum bilirubin and clinical outcomes in COPD Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019
Chronic stress affects lung sphingosine kinase isoenzymes and increases the risk of lung infections Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010
The prevalence of low hemoglobin levels in patients with COPD stratified for disease stage Source: Eur Respir J 2004; 24: Suppl. 48, 63s Year: 2004
Association of dyspnoea, mortality and resource use in hospitalised patients Source: Eur Respir J, 58 (3) 1902107; 10.1183/13993003.02107-2019 Year: 2021
Vitamin D levels and risk of infection, assessment for disease severity, and predictor of mortality in the Chinese intensive care units: A prospective cohort study Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013
Association of hyponatremia with increased mortality in tuberculosis Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis Year: 2021